EP4058148
Skömmtunaráætlun fyrir and-BCMA miðla
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
8.5.2020EP published:
13.3.2024EP application number:
20729951.2
EP translation filed:
29.4.2024Grant published:
15.6.2024EPO information:
European Patent Register
Max expiry date:
7.5.2040Expiry date:
7.5.2026Next due date:
31.5.2026
Title in English:
DOSING REGIMEN FOR ANTI-BCMA AGENTSLanguage of the patent:
English
Timeline
Today
8.5.2020EP application
13.3.2024EP Publication
29.4.2024Translation submitted
15.6.2024Registration published
7.5.2026Expires
Owner
Name:
Amgen Research (Munich) GmbHAddress:
Staffelseestrasse 2, 81477 München, DE
Name:
Amgen Inc.Address:
One Amgen Center Drive, Thousand Oaks, California 91320-1799, US
Inventor
Name:
STIEGLMAIER, JuliaAddress:
81477 Muenchen, DE
Name:
HUBER, BirgitAddress:
81477 Muenchen, DE
Name:
MINELLA, AlexanderAddress:
Thousand Oaks, California 91320, US
Name:
UPRETI, VijayAddress:
Thousand Oaks, California 91320, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
19208417Date:
11.11.2019Country:
EP
Classification
Categories:
A61P 35/00, A61K 39/00, A61K 39/395, C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 19.4.2024
Expires: 7.5.2025
Payer: Árnason Faktor ehf.
Number: 6
Paid: 5.5.2025
Expires: 7.5.2026
Payer: Árnason Faktor ehf.